ATE269060T1 - Verfahren zur herstellung von festen dosierungsformen - Google Patents

Verfahren zur herstellung von festen dosierungsformen

Info

Publication number
ATE269060T1
ATE269060T1 AT99105799T AT99105799T ATE269060T1 AT E269060 T1 ATE269060 T1 AT E269060T1 AT 99105799 T AT99105799 T AT 99105799T AT 99105799 T AT99105799 T AT 99105799T AT E269060 T1 ATE269060 T1 AT E269060T1
Authority
AT
Austria
Prior art keywords
dosage forms
solid dosage
producing solid
employed
mixture
Prior art date
Application number
AT99105799T
Other languages
German (de)
English (en)
Inventor
Stephan Kothrade
Gunther Berndl
Dirk Simon
Axel Sanner
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Application granted granted Critical
Publication of ATE269060T1 publication Critical patent/ATE269060T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F279/00—Macromolecular compounds obtained by polymerising monomers on to polymers of monomers having two or more carbon-to-carbon double bonds as defined in group C08F36/00
    • C08F279/02—Macromolecular compounds obtained by polymerising monomers on to polymers of monomers having two or more carbon-to-carbon double bonds as defined in group C08F36/00 on to polymers of conjugated dienes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L51/00—Compositions of graft polymers in which the grafted component is obtained by reactions only involving carbon-to-carbon unsaturated bonds; Compositions of derivatives of such polymers
    • C08L51/04—Compositions of graft polymers in which the grafted component is obtained by reactions only involving carbon-to-carbon unsaturated bonds; Compositions of derivatives of such polymers grafted on to rubbers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT99105799T 1998-03-23 1999-03-22 Verfahren zur herstellung von festen dosierungsformen ATE269060T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19812688A DE19812688A1 (de) 1998-03-23 1998-03-23 Verfahren zur Herstellung von festen Dosierungsformen

Publications (1)

Publication Number Publication Date
ATE269060T1 true ATE269060T1 (de) 2004-07-15

Family

ID=7861972

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99105799T ATE269060T1 (de) 1998-03-23 1999-03-22 Verfahren zur herstellung von festen dosierungsformen

Country Status (6)

Country Link
US (2) US7022344B1 (enExample)
EP (1) EP0950404B1 (enExample)
JP (1) JP4813634B2 (enExample)
AT (1) ATE269060T1 (enExample)
CA (1) CA2264287C (enExample)
DE (2) DE19812688A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19814739A1 (de) * 1998-04-02 1999-10-07 Basf Ag Verwendung von Polyalkylenoxid-haltigen Pfropfpolymerisaten als Solubilisatoren
DE19847618A1 (de) * 1998-10-15 2000-04-20 Basf Ag Verfahren zur Herstellung von festen Dosierungsformen
CA2391707C (en) * 1999-07-30 2010-05-11 Smithkline Beecham Plc Multi-component pharmaceutical dosage form
DE10026698A1 (de) * 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
GB0102342D0 (en) 2001-01-30 2001-03-14 Smithkline Beecham Plc Pharmaceutical formulation
AU2004232370B2 (en) * 2003-04-21 2009-12-10 Euro-Celtique S.A. Tamper resistant dosage form comprising co-extruded, adverse agent particles and process of making same
TW200526274A (en) 2003-07-21 2005-08-16 Smithkline Beecham Plc Pharmaceutical formulations
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
CA2548834C (en) * 2003-12-09 2009-08-11 Euro-Celtique S.A. Tamper resistant co-extruded dosage form containing an active agent and an adverse agent and process of making same
JP4907514B2 (ja) * 2005-01-28 2012-03-28 株式会社リバース・プロテオミクス研究所 効率的にターゲット分子を探索する方法
WO2006125450A1 (en) * 2005-05-26 2006-11-30 Atef Mohammed Mostafa Darwish Rectal and vaginal suppositories containing misoprostol
EP1920767A1 (en) * 2006-11-09 2008-05-14 Abbott GmbH & Co. KG Melt-processed imatinib dosage form
EP2219624A2 (en) 2007-11-08 2010-08-25 Glaxo Group Limited Pharmaceutical formulations
DE102008059206A1 (de) * 2008-11-27 2010-06-10 Bayer Schering Pharma Aktiengesellschaft Pharmazeutische Darreichungsform enthaltend Nifedipin oder Nisoldipin und einen Angiotensin-II Antagonisten und/oder ein Diuretikum
RU2013118252A (ru) 2010-09-22 2014-10-27 МакНЕЙЛ-ППС, ИНК. Производство таблеток из порошковой смеси, обработанной излучением
US9511028B2 (en) 2012-05-01 2016-12-06 Johnson & Johnson Consumer Inc. Orally disintegrating tablet

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1043039A (en) * 1973-01-29 1978-11-21 Robert D. Lundberg Multiphase block and graft copolymers comprising a hydrophilic continuous phase and hydrophobic domains
FR2433949A1 (fr) * 1978-08-25 1980-03-21 Commissariat Energie Atomique Substrat hydrophobe apte a liberer une substance chimique
ATE37983T1 (de) * 1982-04-22 1988-11-15 Ici Plc Mittel mit verzoegerter freigabe.
DE3612212A1 (de) 1986-04-11 1987-10-15 Basf Ag Verfahren zur herstellung von festen pharmazeutischen formen
DE3612211A1 (de) 1986-04-11 1987-10-15 Basf Ag Kontinuierliches verfahren zum tablettieren
DE3812567A1 (de) 1988-04-15 1989-10-26 Basf Ag Verfahren zur herstellung pharmazeutischer mischungen
DE3830353A1 (de) 1988-09-07 1990-03-15 Basf Ag Verfahren zur kontinuierlichen herstellung von festen pharmazeutischen formen
DE4138513A1 (de) * 1991-11-23 1993-05-27 Basf Ag Feste pharmazeutische retardform
FR2699406B1 (fr) * 1992-12-21 1995-03-10 Commissariat Energie Atomique Films à base de copolymères, leurs applications dans des systèmes transdermiques et leurs procédés de préparation.
KR970701739A (ko) 1994-03-04 1997-04-12 브라운 데이비드 피. 블록 공중합체와 그라프트 공중합체 및 이들과 연관된 방법(Block and graft copolymers and methods relating thereto)

Also Published As

Publication number Publication date
DE19812688A1 (de) 1999-09-30
JP4813634B2 (ja) 2011-11-09
US20050129757A1 (en) 2005-06-16
CA2264287C (en) 2008-10-07
DE59909717D1 (de) 2004-07-22
EP0950404A3 (de) 1999-12-29
US7022344B1 (en) 2006-04-04
JPH11322585A (ja) 1999-11-24
CA2264287A1 (en) 1999-09-23
US7419685B2 (en) 2008-09-02
EP0950404B1 (de) 2004-06-16
EP0950404A2 (de) 1999-10-20

Similar Documents

Publication Publication Date Title
ATE269060T1 (de) Verfahren zur herstellung von festen dosierungsformen
ATE220897T1 (de) Verfahren zur herstellung von festen dosierungsformen
ATE253352T1 (de) Verwendung einer zusammensetzung enthaltend polyether block copolymere
DK0711314T5 (da) Viskositetsmodificeret lactidpolymersammensætning, og fremgangsmåde til fremstilling deraf
ATE265239T1 (de) Mischung von bioresorbierbaren polymeren enthaltend ein pga-haltiges blockcopolymer und ein zweites makrophasengetrenntes polymer
ATE259217T1 (de) Flüssige zusammensetzungen mit kontrollierter freigabe mit niedrigem initialfreisetzungsstoss des wirkstoffs
DE59913682D1 (de) Verfahren zur Herstellung von festen Dosierungsformen
DE69528852D1 (de) Hydromorphontherapie
NO974337D0 (no) Lagringsstabile legemiddelformer
GR880100012A (en) New surgical matters and dispositions
PL340545A1 (en) Poly (vinylamine) based jelly superabsorbens and method of obtaining them
BR0210335A (pt) Copolìmero de blocos, e, composição
WO2002050144A3 (en) Polymeric biomaterials containing silsesquixane monomers
ATE74751T1 (de) Oestradiol-implantat und verfahren zu seiner herstellung.
TR199900563T2 (xx) Kat� dozaj bi�imlerinin kal�ptan �ekme yoluyla �retiminin usul�.
MXPA03011440A (es) Composicion de liberacion sostenida y proceso para producirla.
IL157531A0 (en) Erodible polymers for injection
ATE173578T1 (de) Implantierbare formkörper zur verabreichung von wirkstoffen an pflanzen
KR910009241A (ko) 치근막 질환 치료용 서방성 조성물
NO953995D0 (no) Ionenolymere som anthelmintica i dyr
ATE24742T1 (de) Aethylen-propylen copolymernahtmaterial.
AU6213190A (en) Blends of carbonate polymer, polyacetal and compatibilizer
BR9510368A (pt) Juntas de vedação especialmente para refrigeradores com base em polímero anolefina

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee